nivolumab
bms
['opdivo', 'check,mate,76k', 'nivo', 'nivolumab', 'bristol', '$bmy']
first out// $bmy: bristol myers squibb presents data from checkmate -76k showing opdivo (nivolumab) reduced the risk of recurrence or death by 58% versus placebo in patients with completely resected stage iib or iic
News platform.
Real-time market news alerts.